Holst also synthesised a peptide based on the newly discovered gene sequence for GLP-1 reported by Bell
Arafa NM, Marie MA, AlAzimi SA
What Employers Should Do Now: a 2026 GLP-1 Cost Containment Strategy Require documented medical criteria for every pre-authorisation At a minimum: BMI 30, or BMI 27 with comorbidity (diabetes, hypertension, dyslipidaemia, sleep apnea, etc.) Pre-authorization should include: Baseline clinical assessment
These numbers are the kind that make neurologists take notice
These risks make it essential that GLP-1 drugs are only taken under the supervision of registered medical practitioner/specialists
When to call your provider Contact your healthcare provider if you are considering a permanent schedule change and are currently in the titration (dose escalation) phase of treatment